Peake P, Szelke M, Jones D M, Singleton A, Sueiras-Diaz J, Lachmann P J
Prince Henry Hospital, Little Bay, NSW, Australia.
Clin Exp Immunol. 1990 Mar;79(3):454-8. doi: 10.1111/j.1365-2249.1990.tb08111.x.
We have investigated the development of substrate-based inhibitors of complement enzymes. Sequences around the scissile Arg77-Ser78 bond of C3 have been synthesized and tested as inhibitors of C3 convertase. The best inhibition was found with the tetrapeptide Ac-Arg-Ser-Asn-Leu-OH (H-576); extending this sequence in either direction reduced inhibitory activity. Preliminary experiments with peptides in which the scissile bond--CO--NH--was replaced with non-hydrolysable moieties such as--CO--CH2--(H-497) and--CH2--NH--(H-336) failed to show enhanced inhibition. One of the longer chain inhibitors H-416 containing DArg77-Ser78 was unexpectedly found to potentiate iC3 cleavage by factors I and H but did not inhibit the intact alternative pathway. The same peptide also bound to factor H. It is concluded that the binding requirements of the C3 convertase are more sophisticated than can be satisfactorily imitated simply by linear sequences around the scissile bond of C3.
我们研究了基于底物的补体酶抑制剂的开发。已合成了C3中可裂解的Arg77-Ser78键周围的序列,并将其作为C3转化酶的抑制剂进行了测试。发现四肽Ac-Arg-Ser-Asn-Leu-OH(H-576)具有最佳抑制作用;向任一方向延长该序列都会降低抑制活性。用其中可裂解键(-CO-NH-)被不可水解部分如-CO-CH2-(H-497)和-CH2-NH-(H-336)取代的肽进行的初步实验未能显示出增强的抑制作用。意外地发现,一种含有DArg77-Ser78的较长链抑制剂H-416可增强因子I和H对iC3的裂解作用,但不抑制完整的替代途径。同一肽也与因子H结合。得出的结论是,C3转化酶的结合要求比仅通过C3可裂解键周围的线性序列就能令人满意地模拟的情况更为复杂。